ATE137242T1 - Kovalente-ther lipidnukleosid-konjugate - Google Patents

Kovalente-ther lipidnukleosid-konjugate

Info

Publication number
ATE137242T1
ATE137242T1 AT91912194T AT91912194T ATE137242T1 AT E137242 T1 ATE137242 T1 AT E137242T1 AT 91912194 T AT91912194 T AT 91912194T AT 91912194 T AT91912194 T AT 91912194T AT E137242 T1 ATE137242 T1 AT E137242T1
Authority
AT
Austria
Prior art keywords
conjugates
lipidenucleoside
ther
covalent
deoxythymidine
Prior art date
Application number
AT91912194T
Other languages
English (en)
Inventor
Claude Piantadosi
Canio J Marasco Jr
Louis S Kucera
Original Assignee
Univ Wake Forest
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wake Forest, Univ North Carolina filed Critical Univ Wake Forest
Application granted granted Critical
Publication of ATE137242T1 publication Critical patent/ATE137242T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT91912194T 1990-06-15 1991-06-14 Kovalente-ther lipidnukleosid-konjugate ATE137242T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53900190A 1990-06-15 1990-06-15

Publications (1)

Publication Number Publication Date
ATE137242T1 true ATE137242T1 (de) 1996-05-15

Family

ID=24149332

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91912194T ATE137242T1 (de) 1990-06-15 1991-06-14 Kovalente-ther lipidnukleosid-konjugate

Country Status (7)

Country Link
EP (1) EP0533825B1 (de)
JP (1) JPH05507929A (de)
AT (1) ATE137242T1 (de)
AU (1) AU660417B2 (de)
CA (1) CA2085354C (de)
DE (1) DE69119074T2 (de)
WO (1) WO1991019726A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US5411947A (en) * 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
US5543389A (en) * 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization Covalent polar lipid-peptide conjugates for use in salves
US5827819A (en) * 1990-11-01 1998-10-27 Oregon Health Sciences University Covalent polar lipid conjugates with neurologically active compounds for targeting
US5543390A (en) 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting
JPH07500573A (ja) * 1991-07-12 1995-01-19 ネクススター・ファーマシューティカルズ・インコーポレイテッド 抗ウィルス性リポヌクレオシド：ｂ型肝炎の治療
US5484911A (en) * 1993-04-01 1996-01-16 Health Research, Inc. Nucleoside 5'-diphosphate conjugates of ether lipids
KR0125779B1 (ko) * 1993-12-04 1997-12-19 김승호 뉴클레오시드 화합물 및 이의 제조방법
US7135584B2 (en) 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
CA2197319C (en) * 1994-08-29 2009-01-27 Louis S. Kucera Lipid analogs for treating viral infections
US20020106363A1 (en) * 1994-11-12 2002-08-08 Dieter Herrmann Lipid cleavage enzyme
DE19505168A1 (de) * 1995-02-16 1996-08-22 Boehringer Mannheim Gmbh Spezifische Lipidkonjugate von Nucleosid-Diphosphonaten und deren Verwendung als Arzneimittel
EP0917473A1 (de) * 1996-07-23 1999-05-26 Oregon Health Sciences University Kovalente polar-lipid-konjugate mit biologisch aktiven mitteln zur anwendung in salben
DE19855963A1 (de) * 1998-12-04 2000-06-08 Herbert Schott Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung
IT1306129B1 (it) * 1999-04-13 2001-05-30 Sigma Tau Ind Farmaceuti Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti
US7026469B2 (en) 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US6670341B1 (en) * 1999-10-28 2003-12-30 Wake Forest University Health Sciences Compositions and methods for double-targeting virus infections and targeting cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
US7551837B2 (en) 2001-08-31 2009-06-23 Thomson Licensing Sequence counter for an audio visual stream
US8101745B2 (en) 2004-12-16 2012-01-24 The Regents Of The University Of California Lung-targeted drugs
US7749983B2 (en) 2006-05-03 2010-07-06 Chimerix, Inc. Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
WO2008118879A2 (en) * 2007-03-23 2008-10-02 Ardea Biosciences, Inc. Antiviral compositions comprising 2 compounds
JP6462659B2 (ja) 2013-03-15 2019-01-30 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 非環式ヌクレオシドホスホン酸ジエステル
AU2015317972B2 (en) 2014-09-15 2019-10-17 The Regents Of The University Of California Nucleotide analogs
US10377782B2 (en) 2015-09-15 2019-08-13 The Regents Of The University Of California Nucleotide analogs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291024A (en) * 1978-04-10 1981-09-22 Turcotte Joseph G Cytotoxic liponucleotide analogs
US4622392A (en) * 1984-06-21 1986-11-11 Health Research Inc. (Roswell Park Division) Thiophospholipid conjugates of antitumor agents
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
DE3612636C2 (de) * 1985-04-15 1993-11-18 Asahi Chemical Ind Nucleosid-Phospholipid-Komplexe
EP0262876B1 (de) * 1986-09-27 1992-04-29 Toyo Jozo Kabushiki Kaisha Nukleosid-Phospholipid-Konjugat

Also Published As

Publication number Publication date
CA2085354A1 (en) 1991-12-16
DE69119074D1 (de) 1996-05-30
EP0533825A4 (en) 1993-06-02
EP0533825A1 (de) 1993-03-31
AU8059791A (en) 1992-01-07
CA2085354C (en) 2002-08-27
EP0533825B1 (de) 1996-04-24
WO1991019726A1 (en) 1991-12-26
DE69119074T2 (de) 1996-12-12
AU660417B2 (en) 1995-06-29
JPH05507929A (ja) 1993-11-11

Similar Documents

Publication Publication Date Title
ATE137242T1 (de) Kovalente-ther lipidnukleosid-konjugate
YU78291A (sh) 1,3-oksatiolanski nukleozidni analozi
ATE75142T1 (de) Dhp-manteltablette.
MY103388A (en) Azithromycin and derivatives as antiprotozoal agents
FI863652A0 (fi) 7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning.
FR2601675B1 (fr) Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
ES2138969T3 (es) Combinacion de nucleosidos antivirales.
MY107843A (en) Anti-viral compounds.
IT1226825B (it) Derivati 4' fosfato di glucosidi della epipodofillotossina e relative composizioni farmaceutiche.
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
DK393187A (da) Laegemiddel med antitumorvirkning
ATE124936T1 (de) 5-benzyl barbitursäurederivate.
MX9203320A (es) Composicion antialergica que contiene compuestos biciclicos switterionicos.
SE8600998D0 (sv) Parenterala fenytoinpreparat
ES2097297T3 (es) Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ATE100098T1 (de) Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen.
FI891283A0 (fi) Ifosfamid-mesna-lyofilisat och foerfarande foer dess framstaellning.
SE8205905L (sv) 1,4-dihydropyridinforeningar
KR880007080A (ko) 제약학적 생성물
IT1232819B (it) Impiego di sorgenti di nucleobasi per stimolare la funzione immunitaria, relativo procedimento e composizioni farmaceutiche contenenti una tale sorgente di nucleobasi
ES2104917T3 (es) Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos.
ES2067780T3 (es) 2'-desoxi-2'-metilidenocitidina dihidrato, metodos para su produccion y composiciones.
ES2086409T3 (es) Imidazolinas sustituidas en posicion 2 y preparacion y uso de las mismas.
DE3060669D1 (en) Phenylalanyl-tryptophan derivatives, pharmaceutical compositions containing them, their preparation and use
SE8504657D0 (sv) Nya 5-fluor-2'-deoxiuridinderivat och slater derav, forfarande for deras framstellning och antitumormedel innehallande dessa

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee